ARCHIVES

Arimidex Continues To Show Improvement Over Tamoxifen

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

ACCC Planning Session Considers Community Impact

August 31, 1979

NCI Approved Clinical Trials

May 28, 2010

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988